rs774020683
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004999.4(MYO6):c.1079-5A>G variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000251 in 1,596,088 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004999.4 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO6 | NM_004999.4 | c.1079-5A>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000369977.8 | NP_004990.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO6 | ENST00000369977.8 | c.1079-5A>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_004999.4 | ENSP00000358994 | A1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000822 AC: 2AN: 243270Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 131712
GnomAD4 exome AF: 0.00000208 AC: 3AN: 1443902Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 718888
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 21, 2015 | Variant classified as Uncertain Significance - Favor Benign. The c.1079-5A>G var iant in MYO6 has not been previously reported in individuals with hearing loss b ut has been identified in 1/7180 African chromosomes by the Exome Aggregation Co nsortium (ExAC, http://exac.broadinstitute.org). While this variant is located i n the 3' splice region, computational tools do not suggest an impact to splicing . The nucleotide position affected by the variant is not highly conserved across species and 5 mammals carry a guanine (G) at this position, supporting that the change may be tolerated. However, this information is not predictive enough to rule out pathogenicity. In summary, while the clinical significance of the c.107 9-5A>G variant is uncertain, these data suggest that it is more likely to be ben ign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at